Diazepam Buccal Film
Phase 2Completed 0 views this week 0 watching💤 Quiet
Interest: 29/100
29
Development Stage
✓
Pre-clinical✓
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Epilepsy
Conditions
Epilepsy
Trial Timeline
Aug 31, 2017 → Mar 11, 2020
NCT ID
NCT03222349About Diazepam Buccal Film
Diazepam Buccal Film is a phase 2 stage product being developed by Aquestive Therapeutics for Epilepsy. The current trial status is completed. This product is registered under clinical trial identifier NCT03222349. Target conditions include Epilepsy.
What happened to similar drugs?
20 of 20 similar drugs in Epilepsy were approved
Approved (20) Terminated (6) Active (0)
Hype Score Breakdown
Clinical
12
Activity
8
Company
9
Novelty
0
Community
0
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT03222349 | Phase 2 | Completed |
Competing Products
20 competing products in Epilepsy
| Product | Company | Stage | Hype Score |
|---|---|---|---|
| perampanel | Eisai | Phase 2 | 35 |
| Lacosamide | UCB | Phase 3 | 40 |
| Zonisamide + Placebo | Eisai | Phase 3 | 32 |
| Zonegran | Eisai | Approved | 35 |
| perampanel + perampanel | Eisai | Phase 1 | 29 |
| Perampanel + Placebo | Eisai | Approved | 35 |
| perampanel | Eisai | Approved | 35 |
| E2007 + Placebo | Eisai | Phase 2 | 35 |
| Placebo + Rufinamide | Eisai | Phase 3 | 40 |
| E2007 (perampanel) + Placebo | Eisai | Phase 2 | 35 |
| Perampanel Oral Tablet | Eisai | Approved | 43 |
| perampanel | Eisai | Phase 3 | 40 |
| Perampanel | Eisai | Pre-clinical | 26 |
| Zonisamide + Carbamazepine | Eisai | Phase 3 | 40 |
| Perampanel | Eisai | Approved | 43 |
| Perampanel and Microgynon-30 + Perampanel and Microgynon-30 | Eisai | Phase 1 | 29 |
| Perampanel | Eisai | Phase 2 | 35 |
| Zonisamide + Placebo | Eisai | Phase 3 | 40 |
| zonisamide low dose group + zonisamide high dose group | Eisai | Approved | 43 |
| E2007 + E2007 + Placebo | Eisai | Phase 2 | 35 |